Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UDCA for Gallstone Prevention After Gastrectomy (PEGASUS-D Extension)
NCT05410535Phase 4Completed
- Sponsor
- Daewoong Pharmaceutical
- Start
- Sep 2021
- Primary completion
- Oct 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of ursodeoxycholic acid in cholelithiasis, sponsored by Daewoong Pharmaceutical. Started Sep 2021; status: completed.
02
Drugs
ursodeoxycholic acid
03
Conditions
cholelithiasis
Beyond the preview
Go deeper on NCT05410535.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05410535.